occlude

(redirected from occluding)
Also found in: Dictionary, Thesaurus, Legal, Encyclopedia.

occlude

 [ŏ-klo̳d´]
1. to fit close together.
2. to close tight.
3. to obstruct.

oc·clude

(ŏ-klūd'),
1. To close or bring together.
2. To enclose, as in an occluded virus.
[see occlusion]

occlude

/oc·clude/ (ŏ-klldbomacd´) to fit close together; to close tight; to obstruct or close off.

occlude

(ə-klo͞od′)
v.
1. To cause to become closed; obstruct.
2. To prevent the passage of.
3. To bring together the upper and lower teeth in proper alignment for chewing.
4. To enclose a virus, as in an inclusion body.

oc·clud′ent adj.

occlude

See occlusion.

oc·clude

(ŏ-klūd')
1. To close, plug, obstruct, or bring together.
2. To enclose, as in an occluded virus.
See: occlusion

oc·clude

(ŏ-klūd')
1. To close or bring together.
2. To enclose, as in an occluded virus

occlude (ōklood´),

v to close together. To bring together; to shut. To bring the mandibular teeth into contact with the maxillary teeth.

occlude

to fit close together; to close tight; to obstruct or close off.
References in periodicals archive ?
For occlusion type bars, there are supplementary omega, theta, phase, and threshold fields that control the spacing, orientation, and thickness of the occluding noise bars.
The automatic segmentation process leverages this property to estimate the locations of the occluding pixels by correlating the left and right input images and looking for a sharp peak in the correspondence.
If a dentist is performing a round-house bridge on a patient, obtaining a bite registration can be challenging because when all of the teeth are prepared, there maybe no natural teeth occlusion but just abutments occluding into the opposing arch.
based in Rockland, Massachusetts, is a medical device company focused on embolotherapy, the treatment of uterine fibroids, tumors and vascular malformations by occluding their blood supply.
based in Rockland, Massachusetts, is a medical device company focused on embolotherapy, the treatment of tumors and vascular malformations by occluding their blood supply.
BIOSPHERE MEDICAL, (NASDAQ:BSMD), a medical device company that is pioneering the use of bioengineered microspheres to treat hypervascularized tumors and vascular malformations by occluding their blood supply, will hold its quarterly conference call to discuss first quarter results on Wednesday, October 29, 2003, at 11:00 a.
Nasdaq: BSMD), a medical device company that is pioneering the use of bioengineered microspheres to treat hypervascularized tumors and vascular malformations by occluding their blood supply would like to invite interested parties to listen to a replay of the presentation they made yesterday at the UBS Warburg Global Life Sciences Health Care Conference.